Autolus Therapeutics plc of London, X0, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-23. The offering totals $200.0M, of which $200.0M was reported sold. Industry: Other.
| Name | Role | Location |
|---|---|---|
| Joseph H Anderson | Director | London, X0 |
| Robert H Azelby | Director | London, X0 |
| Linda H Bain | Director | London, X0 |
| John H Berriman | Director | London, X0 |
| Cynthia H Butitta | Director | London, X0 |
| Robert H Iannone | Director | London, X0 |
| Christian Itin | Director | London, X0 |
| John H Johnson | Director | Branchburg, NJ |
| Elisabeth H Leiderman | Director | London, X0 |
| Martin H Murphy | Director | San Francisco, CA |
| William D Young | Director | London, X0 |
| Edgar Braendle | Executive Officer | London, X0 |
| David Brochu | Executive Officer | London, X0 |
| Robert Dolski | Executive Officer | London, X0 |
| Christian Itin | Executive Officer | London, X0 |
| Martin Pule | Executive Officer | London, X0 |
| Brent Rice | Executive Officer | London, X0 |
| Christopher Vann | Executive Officer | London, X0 |